0001104659-23-128727.txt : 20231222
0001104659-23-128727.hdr.sgml : 20231222
20231222142119
ACCESSION NUMBER: 0001104659-23-128727
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231213
FILED AS OF DATE: 20231222
DATE AS OF CHANGE: 20231222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HEALY JAMES
CENTRAL INDEX KEY: 0001245624
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 231509288
MAIL ADDRESS:
STREET 1: 3000 SAND HILL ROAD, 4-250
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
4
1
tm2333601-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-12-13
0
0001604821
Natera, Inc.
NTRA
0001245624
HEALY JAMES
C/O SOFINNOVA INVESTMENTS, INC.
3000 SAND HILL ROAD, 4-250
MENLO PARK
CA
94025
1
0
0
0
0
Common Stock
2023-12-13
4
S
0
644000
58.75
D
0
I
by Sofinnova Management VIII, L.L.C.
Common Stock
1550280
I
by Sofinnova Venture Partners IX, L.P.
Common Stock
42236
D
Includes 644,000 shares of Common Stock of the Issuer received by Sofinnova Management VIII, L.L.C. ("SM VIII") from a pro-rata in-kind distribution of Common Stock of the Issuer by Sofinnova Venture Partners VIII, L.P. ("SVP VIII") without consideration to the partners of SVP VIII in accordance with the limited partnership agreement of SVP VIII. In prior reports, the Reporting Person reported beneficial ownership of 1,550,280 shares of Common Stock of the Issuer held by SVP VIII.
The price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.75 to $59.695, inclusive.The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission,upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
All shares held by SM VIII. Mr. Healy is the managing member of SM VIII. SM VIII is the general partner of SVP VIII. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
All shares held by Sofinnova Venture Partners IX, L.P. ("SVP IX"). Mr. Healy is the managing member of Sofinnova Management IX, L.L.C. ("SM IX"). SM IX is the general partner of SVP IX. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
/s/ Nathalie Auber, Attorney-in-Fact
2023-12-21